Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05026827 · ClinicalTrials.gov registry record · NA
Iyengar Yoga for Prolonged Grief Disorder
A NA study of Prolonged Grief Disorder, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT05026827: Active NA study of Prolonged Grief Disorder, sponsored by Medical College of Wisconsin.
NCT05026827 is a NA study of Prolonged Grief Disorder that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 68 participants, below the 189-participant average among 3 other Prolonged Grief Disorder trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05026827, a NA study of Prolonged Grief Disorder, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
Experiencing the death of a loved one is inevitable for older adults. Before the coronavirus disease 2019 (COVID-19) pandemic, over 2.5 million people died annually in the United States, including 52,000 in Wisconsin alone, and COVID-19 has added to this toll. Each person who dies leaves an average of five grieving people behind. Most grieving older adults are resilient and recover their pre-loss functioning within one year. However, in about 10%, acute grief becomes protracted and debilitating, leading to the development of prolonged grief disorder (PGD), a clinically diagnosable mental health condition. PGD in older adults increases the risk for poorer medical, mental health, and cognitive outcomes; lower quality of life; disability; premature mortality; and suicide. Despite the magnitude of this problem, the neurobiology of PGD in older adults is poorly understood. By using Iyengar Yoga (IY) as a probe for PGD neurobiology, this pilot project aims to address this critical gap.
Primary Outcome
Change in circulating endocannabinoids from baseline to post-intervention
Conditions Studied
Interventions
- OTHER Iyengar Yoga
- OTHER Socialization Control
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Wauwatosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT05026827 still lists
NCT05026827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 189-participant average among 3 other Prolonged Grief Disorder trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Prolonged Grief Disorder appearing as the primary indexed condition, and to 2 interventions - of which Iyengar Yoga is the first listed.
NCT05026827 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05026827 about?
NCT05026827 is a clinical study titled "Iyengar Yoga for Prolonged Grief Disorder". Experiencing the death of a loved one is inevitable for older adults. Before the coronavirus disease 2019 (COVID-19) pandemic, over 2.5 million people died annually in the United States, including 52,000 in Wisconsin alone, and COVID-19 has added to this toll. Each person who dies leaves an average ...
What is the current status of trial NCT05026827?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2021-08-30. Estimated completion is 2026-12.
What conditions does trial NCT05026827 study?
This clinical trial studies the following conditions: Prolonged Grief Disorder.
What interventions are being tested in trial NCT05026827?
The interventions under investigation include: Iyengar Yoga (OTHER), Socialization Control (OTHER).
Who is sponsoring clinical trial NCT05026827?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05026827 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prolonged Grief Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI